NCT02076113

Brief Summary

The purpose of the study is to determine the optimal surgical approach (ventral vs dorsal) for patients with multi-level cervical spondylotic myelopathy (CSM). There are no established guidelines for the management of patients with CSM, which represents the most common cause of spinal cord injury and dysfunction in the US and in the world. This study aims to test the hypothesis that ventral surgery is associated with superior Short Form-36 physical component Score (SF-36 PCS) outcome at one year follow-up compared to dorsal approaches and that both ventral and dorsal surgery improve symptoms of spinal cord dysfunction measured using the modified Japanese Orthopedic Association Score (mJOA). A secondary hypothesis is that health resource utilization for ventral surgery, dorsal fusion, and laminoplasty surgery are different. A third hypothesis is that cervical sagittal balance post-operatively is a significant predictor of SF-36 PCS outcome.

Trial Health

78
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
269

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Apr 2014

Longer than P75 for not_applicable

Geographic Reach
2 countries

16 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Apr 2014Dec 2026

First Submitted

Initial submission to the registry

February 26, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 3, 2014

Completed
29 days until next milestone

Study Start

First participant enrolled

April 1, 2014

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2018

Completed
3.3 years until next milestone

Results Posted

Study results publicly available

July 20, 2021

Completed
5.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Expected
Last Updated

February 20, 2026

Status Verified

February 1, 2026

Enrollment Period

4 years

First QC Date

February 26, 2014

Results QC Date

May 7, 2021

Last Update Submit

February 3, 2026

Conditions

Keywords

cervical spondylotic myelopathydegenerative cervical spondylosisspinal fusion

Outcome Measures

Primary Outcomes (1)

  • Measurement of Change in Short Form 36 (SF 36) Physical Component Score (PCS) From Baseline to 1 Year and 2 Year

    Standardized measure of patient's functional health and well being as reported by the patient. The SF-36 physical component summary (PCS) scores range from 0 to 100, with higher scores representing better quality of life.

    1 year and 2 year

Secondary Outcomes (9)

  • Short Form-36 (SF-36) Physical Component Summary (PCS) Score

    Pre-operative, 1 year and 2 year

  • Oswestry Neck Disability Index (NDI)

    Pre-operative, 1 year and 2 year

  • EuroQol-5D

    Pre-operative, 1 year and 2 year

  • Modified Japanese Orthopedic Association Score mJOA

    Pre-operative and 1 year

  • Sagittal Balance Measurements

    1 year

  • +4 more secondary outcomes

Other Outcomes (1)

  • Short Form-36 (SF-36) Physical Component Summary (PCS) Score by Actual Treatment Groups - Ventral Fusion, Dorsal Fusion, and Dorsal Laminoplasty

    Pre-operative, 1 year and 2 year

Study Arms (2)

Ventral

ACTIVE COMPARATOR

Ventral Decompression with Fusion

Procedure: Ventral (Front) decompression with Fusion

Dorsal

ACTIVE COMPARATOR

Dorsal Decompression with Fusion or Dorsal Laminoplasty

Procedure: Dorsal (Back) Decompression with FusionProcedure: Dorsal (back) Laminoplasty

Interventions

Ventral decompression and fusion will be performed using a multi-level discectomy (including partial or single level corpectomy) with fusion and plating. Allograft will be used at each disc space and all compressive osteophytes will be removed using the operating microscope. Fixation will be performed with rigid, semi-constrained, or dynamic titanium plates to optimize fusion and minimize complications.

Also known as: Anterior Cervical Discectomy and Fusion (ACDF)
Ventral

Dorsal decompression and fusion will be performed using midline cervical laminectomy with the application of lateral mass screws and rods for rigid fixation. All surgeons will use local bone and allograft as needed to perform a lateral mass fusion, which typically will include one level rostral to the levels decompressed.

Also known as: Posterior decompression and fusion
Dorsal

Laminoplasty will be performed using an open-door approach with the application of plates and screws at each treated level. Ceramic or allograft laminar spacers (surgeon's choice) can be used with plates and screws to expand the canal diameter.

Dorsal

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CSM (≥2 levels of spinal cord compression from C3 to C7)
  • Present with ≥2 of the following symptoms/signs: clumsy hands, gait disturbance, hyperreflexia, up going toes, bladder dysfunction.

You may not qualify if:

  • C2-C7 kyphosis\>5º (measured in standing neutral cervical spine radiograph),
  • Segmental kyphotic deformity (defined by ≥3 osteophytes extending dorsal to a C2-C7 dorsal-caudal line measured on cervical spine CT),
  • Structurally significant ossification of posterior longitudinal ligament (OPLL - measured on cervical spine CT),
  • Previous cervical spine surgery
  • Significant active health-related co-morbidity (Anesthesia Class IV or higher).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (16)

University of California- San Francisco

San Francisco, California, 94143, United States

Location

Emory

Atlanta, Georgia, 30329, United States

Location

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

Lahey Hospital and Medical Center

Burlington, Massachusetts, 01805, United States

Location

Washington University School of Medicine- St. Louis

St Louis, Missouri, 63110, United States

Location

Rutgers-New Jersey Medical School

Newark, New Jersey, 07103, United States

Location

Hospital for Special Surgery

New York, New York, 10021, United States

Location

Columbia

New York, New York, 10032, United States

Location

Cleveland Clinic Foundation

Cleveland, Ohio, 44106, United States

Location

MetroHealth

Cleveland, Ohio, 44109, United States

Location

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107, United States

Location

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

Location

University of Utah Health Sciences

Salt Lake City, Utah, 84132, United States

Location

University of Wisconsin

Madison, Wisconsin, 53792, United States

Location

Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States

Location

University Health Network-University of Toronto

Toronto, Ontario, M5T2S8, Canada

Location

Related Publications (6)

  • Ghogawala Z, Martin B, Benzel EC, Dziura J, Magge SN, Abbed KM, Bisson EF, Shahid J, Coumans JV, Choudhri TF, Steinmetz MP, Krishnaney AA, King JT Jr, Butler WE, Barker FG 2nd, Heary RF. Comparative effectiveness of ventral vs dorsal surgery for cervical spondylotic myelopathy. Neurosurgery. 2011 Mar;68(3):622-30; discussion 630-1. doi: 10.1227/NEU.0b013e31820777cf.

    PMID: 21164373BACKGROUND
  • Ghogawala Z, Coumans JV, Benzel EC, Stabile LM, Barker FG 2nd. Ventral versus dorsal decompression for cervical spondylotic myelopathy: surgeons' assessment of eligibility for randomization in a proposed randomized controlled trial: results of a survey of the Cervical Spine Research Society. Spine (Phila Pa 1976). 2007 Feb 15;32(4):429-36. doi: 10.1097/01.brs.0000255068.94058.8a.

    PMID: 17304133BACKGROUND
  • Ghogawala Z, Benzel EC, Heary RF, Riew KD, Albert TJ, Butler WE, Barker FG 2nd, Heller JG, McCormick PC, Whitmore RG, Freund KM, Schwartz JS. Cervical spondylotic myelopathy surgical trial: randomized, controlled trial design and rationale. Neurosurgery. 2014 Oct;75(4):334-46. doi: 10.1227/NEU.0000000000000479.

    PMID: 24991714BACKGROUND
  • Roguski M, Benzel EC, Curran JN, Magge SN, Bisson EF, Krishnaney AA, Steinmetz MP, Butler WE, Heary RF, Ghogawala Z. Postoperative cervical sagittal imbalance negatively affects outcomes after surgery for cervical spondylotic myelopathy. Spine (Phila Pa 1976). 2014 Dec 1;39(25):2070-7. doi: 10.1097/BRS.0000000000000641.

    PMID: 25419682BACKGROUND
  • Ghogawala Z, Terrin N, Dunbar MR, Breeze JL, Freund KM, Kanter AS, Mummaneni PV, Bisson EF, Barker FG 2nd, Schwartz JS, Harrop JS, Magge SN, Heary RF, Fehlings MG, Albert TJ, Arnold PM, Riew KD, Steinmetz MP, Wang MC, Whitmore RG, Heller JG, Benzel EC. Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy: A Randomized Clinical Trial. JAMA. 2021 Mar 9;325(10):942-951. doi: 10.1001/jama.2021.1233.

    PMID: 33687463BACKGROUND
  • Miranda SP, Whitmore RG, Kanter A, Mummaneni PV, Bisson EF, Barker FG 2nd, Harrop J, Magge SN, Heary RF, Fehlings MG, Albert TJ, Arnold PM, Riew KD, Steinmetz MP, Wang MC, Heller JG, Benzel EC, Ghogawala Z. Patients May Return to Work Sooner After Laminoplasty: Occupational Outcomes of the Cervical Spondylotic Myelopathy Surgical Trial. Neurosurgery. 2025 Jan 1;96(1):131-141. doi: 10.1227/neu.0000000000003048. Epub 2024 Jun 24.

Related Links

MeSH Terms

Interventions

DecompressionGene FusionLaminoplasty

Intervention Hierarchy (Ancestors)

TherapeuticsPressureMechanical PhenomenaPhysical PhenomenaRecombination, GeneticGenetic PhenomenaOrthopedic ProceduresNeurosurgical ProceduresSurgical Procedures, Operative

Results Point of Contact

Title
Zoher Ghogawala, MD
Organization
Lahey Hospital & Medical Center

Study Officials

  • Zoher Ghogawala, MD

    Lahey Clinic, Inc.

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2014

First Posted

March 3, 2014

Study Start

April 1, 2014

Primary Completion

March 30, 2018

Study Completion (Estimated)

December 30, 2026

Last Updated

February 20, 2026

Results First Posted

July 20, 2021

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Deidentified data will be available after publication of the trial's primary outcome results. Requests can be emailed to zoher.ghogawala@lahey.org.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be available after publication of the trial's primary results.
Access Criteria
Researchers whose proposed use of data has been approved with a signed data use agreement.

Locations